Okada Naoto 岡田直人

… Alternative Names

OKADA Naoto 岡田直人

Less

Researcher Number	30623269
Other IDs
Affiliation (Current)	2025: 山口大学, 医学部附属病院, 准教授
Affiliation (based on the past Project Information) *help	2025: 山口大学, 医学部附属病院, 准教授 2022 – 2023: 山口大学, 医学部附属病院, 講師 2022: 山口大学, 病院, 講師 2017 – 2021: 徳島大学, 病院, 薬剤師
Review Section/Research Field	Principal Investigator Basic Section 47060:Clinical pharmacy-related / Medical pharmacy Except Principal Investigator Medium-sized Section 90:Biomedical engineering and related fields
Keywords	Principal Investigator 免疫チェックポイント阻害薬 / 免疫関連有害事象 / リアルワールドデータ / 間質性肺炎 / バイオマーカー / 個別化医療 / 日和見感染症 / リアルワールド / がん免疫療法 / ウイルス感染 … More / irAE / 遺伝子多型 / 抗PD1抗体薬 / アルゴリズム / 治療効果予測 / 医療ビッグデータ / 個別化治療 / 抗PD-1抗体 / 医療薬学 / 治療効果 / 末梢血リンパ球 / 個別化投与法 / 抗PD1抗体 … More Except Principal Investigator CARPA / infusion reaction / 抗PEG抗体 / PEG修飾製剤 Less

リアルワールドデータで切り拓くがん免疫薬物療法による日和見感染症の包括的解明Principal Investigator
- Principal Investigator
  
  岡田直人
- Project Period (FY)
  2025 – 2028
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Yamaguchi University
リアルワールドデータの統合解析で拓くがん免疫薬物療法の致死的有害事象回避法の構築Principal Investigator
- Principal Investigator
  
  岡田直人
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Yamaguchi University
Identification of biomarkers for anti-PD1 antibody-related clinical effect based on the combination of laboratory testing and SNP analysis.Principal Investigator
- Principal Investigator
  
  OKADA Naoto
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  The University of Tokushima
PEG修飾タンパクによるアナフィラキシー誘導機構の解明とその制御に関する研究
- Principal Investigator
  
  石田竜弘
- Project Period (FY)
  2019 – 2024
- Research Category
  
  Fund for the Promotion of Joint International Research (Fostering Joint International Research (B))
- Review Section
  
  Medium-sized Section 90:Biomedical engineering and related fields
- Research Institution
  The University of Tokushima
Identification of a biomarker for anti-PD1 antibody-related clinical effect based on the measurement of quantitative and qualitative change of T cellsPrincipal Investigator
- Principal Investigator
  
  OKADA Naoto
- Project Period (FY)
  2017 – 2018
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Medical pharmacy
- Research Institution
  The University of Tokushima

All 2024 2023 2022 2020 2019 2018

All Journal Article Presentation

[Journal Article] Effect of pre-treatment with EGFR-TKIs on immune checkpoint inhibitor-associated interstitial lung disease in lung cancer patients: Analysis using a Japanese claims database2024
- Author(s)
  Okada Naoto、Hamano Hirofumi、Yagi Kenta、Niimura Takahiro、Aizawa Fuka、Goda Mitsuhiro、Zamami Yoshito、Kitahara Takashi、Ishizawa Keisuke
- Journal Title
  
  Int. Journal of Clinical Pharmacology and Therapeutics
  
  Volume: 62 Issue: 02 Pages: 69-76
- DOI
  10.5414/cp204491
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K06724, KAKENHI-PROJECT-22K15340
[Journal Article] Pharmacovigilance Study on Eosinophilic Pneumonia Induced by Anti-MRSA Agents: Analysis Based on the FDA Adverse Event Reporting System2023
- Author(s)
  Okada Naoto、Niimura Takahiro、Saisyo Atsuyuki、Kawaguchi Yoshitaka、Ishizawa Keisuke、Kitahara Takashi
- Journal Title
  
  Open Forum Infectious Diseases
  
  Volume: 10 Issue: 8
- DOI
  10.1093/ofid/ofad414
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K06724, KAKENHI-PROJECT-21H02646
[Journal Article] Characterization of Immune Checkpoint Inhibitor?Induced Myasthenia Gravis Using the US Food and Drug Administration Adverse Event Reporting System2022
- Author(s)
  Niimura Takahiro, Zamami Yoshito, Miyata Koji, Mikami Takahisa, Asada Mizuho, Fukushima Keijo, Yoshino Masaki, Mitsuboshi Satoru, Okada Naoto, et al.
- Journal Title
  
  The Journal of Clinical Pharmacology
  
  Volume: 63 Issue: 4 Pages: 473-479
- DOI
  10.1002/jcph.2187
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K06724, KAKENHI-PROJECT-22K15293, KAKENHI-PROJECT-22K15294, KAKENHI-PROJECT-22K15340, KAKENHI-PLANNED-20H05798, KAKENHI-PROJECT-21H02646, KAKENHI-PROJECT-22K06863, KAKENHI-PROJECT-22K10415, KAKENHI-PROJECT-23K06208, KAKENHI-PROJECT-23K06234, KAKENHI-PROJECT-20K16077
[Journal Article] Risk factors of immune checkpoint inhibitor-related interstitial lung disease in patients with lung cancer: a single-institution retrospective study2020
- Author(s)
  Okada Naoto、Matsuoka Rie、Sakurada Takumi、Goda Mitsuhiro、Chuma Masayuki、Yagi Kenta、Zamami Yoshito、Nishioka Yasuhiko、Ishizawa Keisuke
- Journal Title
  
  Scientific Reports
  
  Volume: 10 Issue: 1 Pages: 13773-13773
- DOI
  10.1038/s41598-020-70743-2
- NAID
  120007190752
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K06785, KAKENHI-PROJECT-19K16414, KAKENHI-PROJECT-19H03668, KAKENHI-PROJECT-20H01062
[Journal Article] Association Between Immune-Related Adverse Events and Clinical Efficacy in Patients with Melanoma Treated With Nivolumab: A Multicenter Retrospective Study2019
- Author(s)
  Okada Naoto、Kawazoe Hitoshi、Takechi Kenshi、Matsudate Yoshihiro、Utsunomiya Ryo、Zamami Yoshito、Goda Mitsuhiro、Imanishi Masaki、Chuma Masayuki、Hidaka Noriaki、Sayama Koji、Kubo Yoshiaki、Tanaka Akihiro、Ishizawa Keisuke
- Journal Title
  
  Clinical Therapeutics
  
  Volume: 41 Issue: 1 Pages: 59-67
- DOI
  10.1016/j.clinthera.2018.11.004
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K06785, KAKENHI-PROJECT-17K18262, KAKENHI-PROJECT-17K15506
[Journal Article] Factors Associated With Immune Checkpoint Inhibitor?Related Myocarditis2019
- Author(s)
  Zamami Yoshito、Niimura Takahiro、Okada Naoto、Koyama Toshihiro、Fukushima Keijo、Izawa-Ishizawa Yuki、Ishizawa Keisuke
- Journal Title
  
  JAMA Oncology
  
  Volume: 5 Issue: 11 Pages: 1635-1635
- DOI
  10.1001/jamaoncol.2019.3113
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K06785, KAKENHI-PROJECT-19K07321, KAKENHI-PROJECT-19K16374, KAKENHI-PROJECT-19K16414, KAKENHI-PROJECT-19J11675
[Journal Article] Pharmacovigilance evaluation of the relationship between impaired glucose metabolism and BCR-ABL inhibitor use by using an adverse drug event reporting database2018
- Author(s)
  Okada Naoto、Niimura Takahiro、Zamami Yoshito、Hamano Hirofumi、Ishida Shunsuke、Goda Mitsuhiro、Takechi Kenshi、Chuma Masayuki、Imanishi Masaki、Ishizawa Keisuke
- Journal Title
  
  Cancer Medicine
  
  Volume: 8 Issue: 1 Pages: 174-181
- DOI
  10.1002/cam4.1920
- NAID
  120006894607
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K06785, KAKENHI-PROJECT-17K18262, KAKENHI-PROJECT-17K15506
[Presentation] 肺がん患者における免疫チェックポイント阻害薬による間質性肺疾患の発現リスク因子の検討：単施設後ろ向き研究2020
- Author(s)
  岡田直人, 座間味義人, 中馬真幸, 合田光寛, 西岡安彦, 石澤啓介
- Organizer
  第24回日本がん分子標的治療学会学術集会
- Data Source
  KAKENHI-PROJECT-19K16414
[Presentation] 発現予防を主体とした副作用マネージメントの構築に向けた臨床薬学研究の展開2018
- Author(s)
  岡田直人
- Organizer
  第28回日本医療薬学会年会　シンポジウム
- Data Source
  KAKENHI-PROJECT-17K15506
[Presentation] ニボルマブによる免疫関連有害事象の発現予測バイオマーカーの探索：多施設共同後ろ向き研究による検討2018
- Author(s)
  岡田直人, 河添仁, 武智研志, 座間味義人, 今西正樹, 中馬真幸, 飛鷹範明, 桐野靖, 中村敏己, 寺岡和彦, 田中亮裕, 石澤啓介
- Organizer
  医療薬学フォーラム 2018・第26回クリニカルファーマシーシンポジウム
- Data Source
  KAKENHI-PROJECT-17K15506

1. 石田竜弘 (50325271)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
2. 安藤英紀 (00735524)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
3. 清水太郎 (30749388)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. 石澤啓介 (60398013)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
5. 座間味義人 (70550250)

# of Collaborated Projects: 1 results

# of Collaborated Products: 6 results
6. GODA Mitsuhiro

# of Collaborated Projects: 0 results

# of Collaborated Products: 3 results
7. 今西正樹

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
8. 武智研志

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
9. 中馬真幸

# of Collaborated Projects: 0 results

# of Collaborated Products: 3 results

Okada Naoto 岡田 直人

OKADA Naoto 岡田 直人

Research Projects

Research Products

Co-Researchers

リアルワールドデータで切り拓くがん免疫薬物療法による日和見感染症の包括的解明Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

リアルワールドデータの統合解析で拓くがん免疫薬物療法の致死的有害事象回避法の構築Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Identification of biomarkers for anti-PD1 antibody-related clinical effect based on the combination of laboratory testing and SNP analysis.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

PEG修飾タンパクによるアナフィラキシー誘導機構の解明とその制御に関する研究

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Identification of a biomarker for anti-PD1 antibody-related clinical effect based on the measurement of quantitative and qualitative change of T cellsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Effect of pre-treatment with EGFR-TKIs on immune checkpoint inhibitor-associated interstitial lung disease in lung cancer patients: Analysis using a Japanese claims database2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Pharmacovigilance Study on Eosinophilic Pneumonia Induced by Anti-MRSA Agents: Analysis Based on the FDA Adverse Event Reporting System2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Characterization of Immune Checkpoint Inhibitor?Induced Myasthenia Gravis Using the US Food and Drug Administration Adverse Event Reporting System2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Risk factors of immune checkpoint inhibitor-related interstitial lung disease in patients with lung cancer: a single-institution retrospective study2020

Author(s)

Journal Title

DOI

NAID

Data Source

[Journal Article] Association Between Immune-Related Adverse Events and Clinical Efficacy in Patients with Melanoma Treated With Nivolumab: A Multicenter Retrospective Study2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Factors Associated With Immune Checkpoint Inhibitor?Related Myocarditis2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Pharmacovigilance evaluation of the relationship between impaired glucose metabolism and BCR-ABL inhibitor use by using an adverse drug event reporting database2018

Author(s)

Journal Title

DOI

NAID

Data Source

[Presentation] 肺がん患者における免疫チェックポイント阻害薬による間質性肺疾患の発現リスク因子の検討：単施設後ろ向き研究2020

Author(s)

Organizer

Data Source

[Presentation] 発現予防を主体とした副作用マネージメントの構築に向けた臨床薬学研究の展開2018

Author(s)

Organizer

Data Source

Okada Naoto 岡田直人

OKADA Naoto 岡田直人